Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Subst Abuse Treat. 2016 Aug 18;72:72–79. doi: 10.1016/j.jsat.2016.08.012

Table 2.

Outcome Variables at Follow up and Process Variables Pre and Post by Voucher Condition: Descriptive Statistics and Univariate Analyses (t-tests or Chi-square Tests)

Variable CV
N (%) or
Mean (SD)
NV
N (%) or
Mean (SD)
Effect Size
d or OR
95% CI
Confirmed 7-day abstinence2
  1 Month 16 (9.3) 13 (7.7) 1.22 0.57, 2.63
  3 Month 9 (5.3) 5 (3.0) 1.81 0.59, 5.52
  6 Month Follow Up 6 (3.6) 3 (1.8) 2.03 0.49, 8.23
  12 Month Follow Up 6 (3.7) 3 (1.8) 2.08 0.51, 8.45
Average no. cigarettes per day1
  1 Month Follow Up 5.28 (5.49) 7.98 (5.49) −0.49* −0.71, −0.27
  3 Month Follow Up 8.84 (7.57) 9.89 (6.19) −0.15 −0.38, 0.08
  6 Month Follow Up 10.87 (8.05) 12.18 (6.59) −0.12 −.057, 0.33
  12 Month Follow Up 11.67 (7.70) 12.78 (7.23) −0.15 −0.40, 0.11
Percent smoking days1
  1 Month Follow Up 77.51 (33.02) 88.33 (25.48) −0.37* −0.59, −0.15
  3 Month Follow Up 82.39 (30.63) 88.40 (25.48) −0.25 −0.46, 0.02
  6 Month Follow Up 88.49 (26.45) 92.30 (21.91) −0.16 −0.40, 0.08
  12 Month Follow Up 87.38 (26.62) 91.53 (22.86) −0.17 −0.42, 0.09
Relapse to any heavy drinking2
  1 Month Follow Up 12 (7.4) 8 (5.1) 1.48 0.59, 3.72
  3 Month Follow Up 23 (15.5) 24 (16.8) 0.91 0.49, 1.70
  6 Month Follow Up 38 (27.5) 35 (26.9) 1.03 0.60, 1.77
  12 Month Follow Up 38 (30.2) 36 (31.6) 0.94 0.54, 1.62
Number of drug use days1
  1 Month Follow Up 1.46 (2.60) 0.36 (0.51) −0.01 −0.23, 0.21
  3 Month Follow Up 3.35 (10.32) 3.87 (12.13) −0.01 −0.24, 0.22
  6 Month Follow Up 7.25 (17.21) 8.69 (20.20) <0.01 −0.23, 0.25
  12 Month Follow Up 21.55 (41.71) 21.82 (43.24) 0.02 −0.23, 0.28
Relapse to any drug use2
  1 Month Follow Up 13 (8.0) 16 (10.2) 0.76 0.36, 1.65
  3 Month Follow Up 38 (49.1) 32 (50.9) 1.19 0.67, 2.06
  6 Month Follow Up 50 (36.2) 42 (32.3) 1.19 0.72, 1.97
  12 Month Follow Up 54 (42.9) 50 (43.9) 0.96 0.58, 1.60
Contemplation Ladder1
  Pretreatment 5.40 (1.63) 5.31 (1.55) 0.06 −0.17, 0.29
  1 Month Follow Up 7.28 (1.73) 6.89 (1.65) 0.23 0.00, 0.46
Self- Efficacy for Smoking
Abstinence1
  Pretreatment 1.78 (0.76) 1.67 (0.70) 0.15 −0.08, 0.38
  1 Month Follow Up 3.10 (1.03) 2.83 (1.03) 0.26 0.03, 0.49
*

p < .001

Note: Sample size for continuous variables at 1 month n = 163 in CV and n = 158 in NCV, at 3 months n = 148 in CV and n = 143 in NCV, at 6 months n = 138 in CV and n = 130 in NCV, and at 12 months n = 126 in CV and n = 114 in NCV.

CV = contingent vouchers condition; NV = noncontingent vouchers condition ; CI = confidence interval

1

Normally distributed variable; effect size is in standardized units of the dependent variable (d).

2

Dichotomous variable; effect size is expressed as an odds ratio.